Isotope diagnostics and treatments
Radionuclide or radioisotope examinations are based on a radioactive tracer that is introduced to the patient’s bloodstream in various ways. The tracer penetrates via normal metabolism into the organ to be examined. In the target organ, the tracer sends radiation which can be observed by means of a gamma or PET camera, for example.
Using this method, it is possible to locate potential cancer metastases and monitor the effectiveness of cancer treatment. Radionuclides are also used in cancer treatment, in which case a radionuclide that has been taken up by the tumor destroys cancer cells through its radiation.
In cancer treatment, the development trend is a more precise diagnosis, which strongly affects the success of the treatments themselves. For this reason, Docrates Cancer Center takes advantage of PET-CT equipment in the treatment of an increasing number of patients: in order to effectively treat cancer, the exact location of the cancer must be known. At Docrates, PET-CT is used for diagnosing cancer, the dose planning of radiotherapy and the assessment of the therapeutic response of new targeted drugs. We have also strongly invested in more specific tracers.
Clinical usefulness is always assessed on a case-by-case basis, and no unnecessary examinations are conducted. At Docrates, patients can access radionuclide examinations fast, and our multi-professional team under the leadership of the Chief Physician of Nuclear Medicine Jukka Kemppainen is responsible for the treatment. PET-CT is a demanding tool, the good utilisation of which requires a great deal of expertise. The producer of the tracers, MAP Medical Technologies, operates in the same building as Docrates Cancer Center. It has its own cyclotron used for the manufacture of tracers and a GMP-level laboratory. There are only a handful of cancer hospitals in the world that can so optimally take advantage of the location of a cyclotron and imaging equipment under the same roof.
Learn more in which cases the isotope treatments are used at Docrates Cancer Center.
Colorectal cancer is a common but rarely talked-about disease
Colorectal cancer is the second most common cancer in Finland, and its level of incidence is increasing. Lifestyles and the...Read more
Breakthroughs in follow-up cancer diagnostics: Recurring cancer can be detected before it reaches full speed
20.4.2023 | A liquid biopsy using markers released into the bloodstream by cancer cells can reveal the possible recurrence of...Read more
Internal radiotherapy is an effective method of treatment for metastatic prostate cancer
14.3.2023 | Docrates Cancer Center studied the effectiveness of 177Lu-PSMA treatment with a 4-week treatment interval for patients with metastatic...Read more
The number of insured patients has more than tripled in five years
9.3.2023 | In 2022, nearly 30% of revenue generated by Docrates Cancer Center’s Finnish patients came from insurance company customers,...Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.
Mon-Thu 8 am-6 pm, Fri 8 am-4 pm (local time)